tiprankstipranks
Black Bird Biotech (BBBT)
OTHER OTC:BBBT
US Market

Black Bird Biotech (BBBT) Stock Price & Analysis

25 Followers

BBBT Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range― - ―
Previous Close$0.01
Volume23.80M
Average Volume (3M)N/A
Market Cap
$98.40K
Enterprise Value$944.92K
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$748.11K
Price to Earnings (P/E)-5.6
Beta5.88
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding1,785,430,168
10 Day Avg. Volume10,091,442
30 Day Avg. VolumeN/A
Standard Deviation1.44
R-Squared0.01
Alpha0.12
Financial Highlights & Ratios
Price to Book (P/B)-0.39
Price to Sales (P/S)4.33
Price to Cash Flow (P/CF)-18.20
P/FCF Ratio0.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue31.09
Enterprise Value/Gross Profit28.62
Enterprise Value/Ebitda-11.70
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

BBBT FAQ

What was Black Bird Biotech’s price range in the past 12 months?
Currently, no data Available
What is Black Bird Biotech’s market cap?
Currently, no data Available
When is Black Bird Biotech’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Black Bird Biotech’s earnings last quarter?
Currently, no data Available
Is Black Bird Biotech overvalued?
According to Wall Street analysts Black Bird Biotech’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
    Does Black Bird Biotech pay dividends?
    Black Bird Biotech does not currently pay dividends.
    What is Black Bird Biotech’s EPS estimate?
    Black Bird Biotech’s EPS estimate for its next earnings report is not yet available.
    How many shares outstanding does Black Bird Biotech have?
    Black Bird Biotech has 984,047,400 shares outstanding.
      What happened to Black Bird Biotech’s price movement after its last earnings report?
      Currently, no data Available
      Which hedge fund is a major shareholder of Black Bird Biotech?
      Currently, no hedge funds are holding shares in BBBT
      ---

      Black Bird Biotech Stock Smart Score

      N/A
      Not Ranked
      1
      2
      3
      4
      5
      6
      7
      8
      9
      10

      Company Description

      Black Bird Biotech

      Digital Development Partners, Inc. engages in owning the distribution and servicing rights to product known as EFT-Phone. Its product consists of a cell phone which uses the Microsoft Operating System. The company was founded on December 22, 2006 and is headquartered in City of Industry, CA.
      ---
      Similar Stocks
      Company
      Price & Change
      Follow
      PDS Biotechnology
      vTv Therapeutics
      Brainstorm Cell Therapeutics
      Popular Stocks
      ---
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis